60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 ...
360Dx

UK Diagnostics Companies Grapple with 'Difficult' Early-Stage Investment Market

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been unthinkable a decade ago, and target the US first.

Mainz Biomed to Attend 2025 Maxim Growth Summit

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in ...
Newseria BIZNES

Global Tumor Blood Testing Market to Reach $9.83 Billion at a Steady 13.2% CAGR by 2029

LONDON, GREATER LONDON, UNITED KINGDOM, October 15, 2025 / EINPresswire.com / -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...